Telix dips as pharma giant abandons US IPO for NASDAQ listing – despite record run
International plans for Telix – proudly boasting its intentions to list on the NASDAQ for a while now – have come to an anticlimactic end.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 15.59pm 14/06/2024 (20 minute delay)
?
Day | ||||||||
---|---|---|---|---|---|---|---|---|
Open | $1.99 | Day High | $2.00 | Day Low | $1.90 | |||
Daily Volume | 1694608 |
Bids | Sellers | |||||
---|---|---|---|---|---|---|
Number | Price | Volume | Number | Price | Volume | |
1 | $1.92 | 1920 | 4 | $1.95 | 47411 |
Directors & Senior Management
Mr. Todd Hannigan | Executive Chairman of the Board |
Mr. Toby Symonds | President, Chief Strategy Officer |
Mr. Anastasios Arima | Chief Executive Officer, Managing Director, Executive Director |
Mrs. Marcela Castro | Chief Financial Officer |
Mr. Scott Sparks | Chief Operating Officer |
Mr. Dominic Allen | Chief Commercial Officer |
Ms. Jeanne Mcmullin | Chief Legal Officer |
Mr. Gregory Swan | Company Secretary |
Ms. Lorraine M. Martin | Non-Executive Independent Director |
Mr. Vaughn Taylor | Non-Executive Independent Director |
Ms. Melissa G. Waller | Non-Executive Independent Director |
Ms. Beverly M. Wyse | Non-Executive Independent Director |
Data source: Refinitiv